• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis.次最大心脏和肺脏评估:一种新型无创试验,用于识别系统性硬化症患者的肺动脉高压。
Arthritis Care Res (Hoboken). 2013 Oct;65(10):1713-8. doi: 10.1002/acr.22051.
2
Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.有肺动脉高压和无肺动脉高压的系统性硬化症患者在进行三分钟阶梯运动后呼气末二氧化碳变化的比较。
Rheumatology (Oxford). 2017 Jan;56(1):87-94. doi: 10.1093/rheumatology/kew365. Epub 2016 Oct 25.
3
Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.应用 CMR 成像无创估计肺动脉压、流量和阻力:来自 ASPIRE 注册研究的推导和前瞻性验证。
JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-1047. doi: 10.1016/j.jcmg.2013.01.013. Epub 2013 Jun 13.
4
Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.弥散量一氧化碳与超声心动图参数在 EUSTAR 系统性硬化症患者队列中识别轻度肺动脉高压的比较。
Chest. 2024 Oct;166(4):837-844. doi: 10.1016/j.chest.2024.05.010. Epub 2024 Jun 6.
5
Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.一氧化碳弥散量降低可预测系统性硬化症患者的肺动脉压处于临界值。
Rheumatol Int. 2019 Nov;39(11):1883-1887. doi: 10.1007/s00296-019-04370-0. Epub 2019 Jul 6.
6
Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.利用肺功能测试提高系统性硬化症中肺动脉高压的检测率。
Arthritis Rheum. 2011 Nov;63(11):3531-9. doi: 10.1002/art.30535.
7
Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.女性系统性红斑狼疮相关肺动脉高压患者的运动能力特征
BMC Cardiovasc Disord. 2018 Mar 23;18(1):56. doi: 10.1186/s12872-018-0783-7.
8
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.特发性肺动脉高压患者血流动力学正常与边缘平均肺动脉压患者的基线特征及随访:PHAROS 注册研究结果。
Ann Rheum Dis. 2012 Aug;71(8):1335-42. doi: 10.1136/annrheumdis-2011-200546. Epub 2012 Feb 2.
9
Cardiopulmonary exercise test predicts right heart catheterization.心肺运动试验可预测右心导管检查。
Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12851. Epub 2017 Nov 17.
10
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.基于证据的系统性硬化症肺动脉高压检测:DETECT 研究。
Ann Rheum Dis. 2014 Jul;73(7):1340-9. doi: 10.1136/annrheumdis-2013-203301. Epub 2013 May 18.

引用本文的文献

1
Implementation of Brief Submaximal Cardiopulmonary Testing in a High-Volume Presurgical Evaluation Clinic: Feasibility Cohort Study.在高容量术前评估诊所实施简短次极量心肺测试:可行性队列研究
JMIR Perioper Med. 2025 Feb 17;8:e65805. doi: 10.2196/65805.
2
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.肺动脉高压:诊断、治疗与新进展。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1472-1487. doi: 10.1164/rccm.202012-4317SO.
3
Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction.门诊环境下次极量心肺运动试验对射血分数保留的心力衰竭的诊断价值。
Pulm Circ. 2020 Nov 25;10(4):2045894020972273. doi: 10.1177/2045894020972273. eCollection 2020 Oct-Dec.
4
Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.有肺动脉高压和无肺动脉高压的系统性硬化症患者在进行三分钟阶梯运动后呼气末二氧化碳变化的比较。
Rheumatology (Oxford). 2017 Jan;56(1):87-94. doi: 10.1093/rheumatology/kew365. Epub 2016 Oct 25.

本文引用的文献

1
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.系统性硬皮病和系统性红斑狼疮相关肺动脉高压。
Eur Respir Rev. 2011 Dec;20(122):277-86. doi: 10.1183/09059180.00003811.
2
The usefulness of submaximal exercise gas exchange to define pulmonary arterial hypertension.亚极量运动气体交换对肺动脉高压的定义的作用。
J Heart Lung Transplant. 2011 Oct;30(10):1133-42. doi: 10.1016/j.healun.2011.03.021. Epub 2011 May 31.
3
Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing.系统性硬化症患者的肺血管病变,通过无创心肺运动试验检测到。
PLoS One. 2010 Dec 13;5(12):e14293. doi: 10.1371/journal.pone.0014293.
4
Ventilatory expired gas at constant-rate low-intensity exercise predicts adverse events and is related to neurohormonal markers in patients with heart failure.恒速低强度运动时的通气呼出气预测心力衰竭患者的不良事件,并与神经激素标志物相关。
J Card Fail. 2009 Aug;15(6):482-8. doi: 10.1016/j.cardfail.2008.12.015. Epub 2009 Feb 10.
5
Changes in causes of death in systemic sclerosis, 1972-2002.1972年至2002年系统性硬化症的死因变化
Ann Rheum Dis. 2007 Jul;66(7):940-4. doi: 10.1136/ard.2006.066068. Epub 2007 Feb 28.
6
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.系统性硬化症中肺动脉高压的早期检测:一项法国全国性前瞻性多中心研究。
Arthritis Rheum. 2005 Dec;52(12):3792-800. doi: 10.1002/art.21433.
7
End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension.原发性肺动脉高压患者的呼气末二氧化碳异常与运动受限
Chest. 2005 May;127(5):1637-46. doi: 10.1378/chest.127.5.1637.
8
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.系统性硬化症相关肺动脉高压的患病率及预后:登记方法的应用
Ann Rheum Dis. 2003 Nov;62(11):1088-93. doi: 10.1136/ard.62.11.1088.
9
End-tidal CO2 pressure decreases during exercise in cardiac patients: association with severity of heart failure and cardiac output reserve.心脏病患者运动期间呼气末二氧化碳分压降低:与心力衰竭严重程度和心输出量储备的关系。
J Am Coll Cardiol. 2000 Jul;36(1):242-9. doi: 10.1016/s0735-1097(00)00702-6.
10
Echocardiographic features of primary pulmonary hypertension.原发性肺动脉高压的超声心动图特征。
J Am Soc Echocardiogr. 1999 Aug;12(8):655-62. doi: 10.1053/je.1999.v12.a99069.

次最大心脏和肺脏评估:一种新型无创试验,用于识别系统性硬化症患者的肺动脉高压。

Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis.

机构信息

Hospital for Special Surgery, New York, New York.

出版信息

Arthritis Care Res (Hoboken). 2013 Oct;65(10):1713-8. doi: 10.1002/acr.22051.

DOI:10.1002/acr.22051
PMID:23740875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4084928/
Abstract

OBJECTIVE

Pulmonary hypertension (PH) is a leading cause of death in patients with systemic sclerosis (SSc; scleroderma). Although right-sided heart catheterization (RHC) is the gold standard for diagnosing PH, it is an invasive test with associated risks. The submaximal heart and pulmonary evaluation (step test) is a noninvasive, submaximal stress test that could be used to identify patients with PH. The purpose of this study is to assess the correlation between change in end tidal carbon dioxide (ΔPETCO2 ) from rest to end-exercise on the step test and mean pulmonary artery pressure (mPAP) on RHC in SSc patients.

METHODS

This is a retrospective cohort study of patients with limited or diffuse cutaneous SSc who were evaluated in an academic cardiology practice between November 2007 and November 2011 and underwent a step test and RHC. Statistical analysis was performed using Spearman's correlation test and multivariable linear regression.

RESULTS

A total of 679 charts were reviewed. Nineteen SSc patients who underwent a step test and RHC were included. ΔPETCO2 was negatively correlated with mPAP (r = -0.82, P < 0.0001). In a multivariable linear regression model evaluating the relationship between ΔPETCO2 and mPAP, controlling for age, sex, and time between and order of step test and RHC, ΔPETCO2 remained the only variable statistically significantly associated with mPAP (P < 0.001). The step test had a sensitivity of 100%, specificity of 75%, positive predictive value of 93.8%, and negative predictive value of 100% for the diagnosis of PH.

CONCLUSION

ΔPETCO2 on the step test has a strong, statistically significant negative correlation with mPAP on RHC.

摘要

目的

肺动脉高压(PH)是系统性硬皮病(SSc;硬皮症)患者死亡的主要原因。尽管右心导管检查(RHC)是诊断 PH 的金标准,但它是一种具有相关风险的侵入性检查。次最大心脏和肺评估(台阶试验)是一种非侵入性的次最大应激试验,可用于识别 PH 患者。本研究的目的是评估台阶试验中休息至运动结束时呼气末二氧化碳(ΔPETCO2)的变化与 RHC 中平均肺动脉压(mPAP)之间的相关性在 SSc 患者中。

方法

这是一项回顾性队列研究,纳入了 2007 年 11 月至 2011 年 11 月在学术心脏病学实践中接受评估的局限性或弥漫性皮肤 SSc 患者,并进行了台阶试验和 RHC。使用 Spearman 相关检验和多变量线性回归进行统计分析。

结果

共回顾了 679 份图表。纳入了 19 名接受台阶试验和 RHC 的 SSc 患者。ΔPETCO2 与 mPAP 呈负相关(r=-0.82,P<0.0001)。在评估 ΔPETCO2 与 mPAP 之间关系的多变量线性回归模型中,控制年龄、性别以及台阶试验和 RHC 之间的时间和顺序,ΔPETCO2 仍然是唯一与 mPAP 统计学显著相关的变量(P<0.001)。台阶试验对 PH 的诊断具有 100%的敏感性、75%的特异性、93.8%的阳性预测值和 100%的阴性预测值。

结论

台阶试验中 ΔPETCO2 与 RHC 中 mPAP 呈强烈的、统计学显著的负相关。